Key facts
- Notable investors include Transpose Platform Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Layrd
- ·The full record, as it builds
Funding rounds
No funding rounds for Layrd are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Layrd
Developer of electronic health record software designed to automate medical pre-charting and document triage. The company's software offers automated chart preparation, document classification, and coding intelligence with citation verification across patient records, enabling medical practitioners to eliminate manual record review while surfacing missed billing opportunities and clinical discrepancies.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- thelayrd.com/
- Ownership
- Privately Held (backing)
Layrd doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Layrd shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Layrd in its N-PORT filings yet. We sweep new filings monthly.